Literature DB >> 20676870

The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.

Brechtje A Grotenhuis1, J Jan B van Lanschot, Winand N M Dinjens, Bas P L Wijnhoven.   

Abstract

The most important risk factor for the development of Barrett's esophagus is the reflux of both gastric and duodenal contents into the esophagus. The reason why Barrett's metaplasia develops only in a minority of patients suffering from gastroesophageal reflux disease remains unknown.The exact mechanism behind the transition of normal squamous epithelium into specialized columnar epithelium is also unclear. It is likely that stem cells are involved in this metaplastic change, as they are the only permanent residents of the epithelium. Several tumorigenic steps that lead to the underlying genetic instability, which is indispensable in the progression from columnar metaplasia to esophageal adenocarcinoma have been described. This review outlines the process of pathogenesis of Barrett's metaplasia and its progression to esophageal adenocarcinoma.

Entities:  

Mesh:

Year:  2010        PMID: 20676870     DOI: 10.1007/978-3-540-70579-6_4

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  3 in total

1.  Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.

Authors:  Peng Cheng; Jian-Sheng Li; Jun Gong; Lian-Feng Zhang; Rong-Zhong Chen
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

2.  Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells.

Authors:  Dunfa Peng; Abbes Belkhiri; Tianling Hu; Rupesh Chaturvedi; Mohammad Asim; Keith T Wilson; Alexander Zaika; Wael El-Rifai
Journal:  Gut       Date:  2011-12-09       Impact factor: 23.059

3.  Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus.

Authors:  Peng Cheng; Jian-Sheng Li; Lian-Feng Zhang; Yong-Zhong Chen; Jun Gong
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.